What is more, Poggio et al. successfully inhibited exosome production from prostate cancer cell lines by the deletion of nSMase2 or Rab27a via the CRISPR/Cas9 system, further modulating exosomal PD-L1 decrease to suppress cancer progression. Here, CD274 is linked to cancer.